Illumina, Inc. (ILMN)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$209.00
-7.82%
Mkt Cap $43.61B
Analyst Ratings
Buy
19
Hold
5
Sell
5
Price Target (80 analysts)
$210.67
Range $155.00 – $260.00
Implied Upside
+0.8%
Consensus $210.67 vs current $209.00